Economic_NewsNovo Nordisk shares drop 15% after poor trial results for new obesity drug Rutt ontrd9 months ago01 mins Post Views: 235 Once-a-week injection achieved less weight loss than rival treatment 0 Reviews Post navigation Previous: Blue Owl is spoiling private credit’s sales pitchNext: Euro Choppy Amongst Numerous Headlines – 23 February 2026
Brazil’s central bank steps in to stem real’s slide since Lula’s re-election Rutt ontrd55 minutes ago 0